Merck said on Sunday it will buy Prometheus Biosciences for about $10.8 billion, building up its presence in immunology.
You are here: Home / Merck to buy Prometheus Biosciences for about $11 billion
Market News and Views
Merck said on Sunday it will buy Prometheus Biosciences for about $10.8 billion, building up its presence in immunology.